XRF Scientific Statistics
Total Valuation
XRF Scientific has a market cap or net worth of AUD 227.45 million. The enterprise value is 220.75 million.
Market Cap | 227.45M |
Enterprise Value | 220.75M |
Important Dates
The last earnings date was Tuesday, November 19, 2024.
Earnings Date | Nov 19, 2024 |
Ex-Dividend Date | Sep 12, 2024 |
Share Statistics
XRF Scientific has 140.40 million shares outstanding. The number of shares has increased by 0.80% in one year.
Current Share Class | n/a |
Shares Outstanding | 140.40M |
Shares Change (YoY) | +0.80% |
Shares Change (QoQ) | +0.43% |
Owned by Insiders (%) | 23.04% |
Owned by Institutions (%) | 2.18% |
Float | 91.13M |
Valuation Ratios
The trailing PE ratio is 25.31 and the forward PE ratio is 22.82.
PE Ratio | 25.31 |
Forward PE | 22.82 |
PS Ratio | 3.71 |
PB Ratio | 4.08 |
P/TBV Ratio | n/a |
P/FCF Ratio | 35.11 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.49, with an EV/FCF ratio of 34.08.
EV / Earnings | 24.84 |
EV / Sales | 3.67 |
EV / EBITDA | 14.49 |
EV / EBIT | 16.07 |
EV / FCF | 34.08 |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.75 |
Quick Ratio | 2.06 |
Debt / Equity | 0.08 |
Debt / EBITDA | 0.31 |
Debt / FCF | 0.72 |
Interest Coverage | 47.76 |
Financial Efficiency
Return on equity (ROE) is 18.07% and return on invested capital (ROIC) is 14.85%.
Return on Equity (ROE) | 18.07% |
Return on Assets (ROA) | 12.84% |
Return on Capital (ROIC) | 14.85% |
Revenue Per Employee | 1.25M |
Profits Per Employee | 185,110 |
Employee Count | 48 |
Asset Turnover | 0.90 |
Inventory Turnover | 1.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.53% in the last 52 weeks. The beta is 0.89, so XRF Scientific's price volatility has been lower than the market average.
Beta (5Y) | 0.89 |
52-Week Price Change | +49.53% |
50-Day Moving Average | 1.65 |
200-Day Moving Average | 1.42 |
Relative Strength Index (RSI) | 41.68 |
Average Volume (20 Days) | 237,292 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XRF Scientific had revenue of AUD 60.12 million and earned 8.89 million in profits. Earnings per share was 0.06.
Revenue | 60.12M |
Gross Profit | 26.55M |
Operating Income | 13.74M |
Pretax Income | 13.46M |
Net Income | 8.89M |
EBITDA | 14.46M |
EBIT | 13.74M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 12.05 million in cash and 4.69 million in debt, giving a net cash position of 7.35 million or 0.05 per share.
Cash & Cash Equivalents | 12.05M |
Total Debt | 4.69M |
Net Cash | 7.35M |
Net Cash Per Share | 0.05 |
Equity (Book Value) | 55.54M |
Book Value Per Share | 0.40 |
Working Capital | 28.75M |
Cash Flow
In the last 12 months, operating cash flow was 8.09 million and capital expenditures -1.61 million, giving a free cash flow of 6.48 million.
Operating Cash Flow | 8.09M |
Capital Expenditures | -1.61M |
Free Cash Flow | 6.48M |
FCF Per Share | 0.05 |
Margins
Gross margin is 44.16%, with operating and profit margins of 22.86% and 14.78%.
Gross Margin | 44.16% |
Operating Margin | 22.86% |
Pretax Margin | 22.40% |
Profit Margin | 14.78% |
EBITDA Margin | 24.06% |
EBIT Margin | 22.86% |
FCF Margin | 10.78% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.44%.
Dividend Per Share | 0.04 |
Dividend Yield | 2.44% |
Dividend Growth (YoY) | 18.18% |
Years of Dividend Growth | 6 |
Payout Ratio | 40.52% |
Buyback Yield | -0.80% |
Shareholder Yield | 1.64% |
Earnings Yield | 3.95% |
FCF Yield | 2.85% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
XRF Scientific has an Altman Z-Score of 10.4.
Altman Z-Score | 10.4 |
Piotroski F-Score | n/a |